Related Experiment Video
Updated: Jan 28, 2026

Toxicity Study of Zinc Oxide Nanoparticles in Cell Culture and in Drosophila melanogaster
Published on: September 19, 2019
Toxic concentrations of exogenously supplied methylglyoxal in hybridoma cell culture
Benjamin M Roy1, Tiffany D Rau, R Robert Balcarcel
1Department of Chemical Engineering, Vanderbilt University, VU Station B # 351604, 2301 Vanderbilt Place, Nashville, Tennessee, 37235-1604, USA.
Abstract:
Concentrations at which methylglyoxal, a by-product of cellular metabolism, can be toxic to hybridoma cell cultures were determined using exogenously supplied doses. Trypan blue cell counts of 6-well cultures incubated for 24 h with various methylglyoxal concentrations revealed inhibition of cell growth at 300 muM and higher, with a median inhibitory concentration of 490+/-20 muM. The primary mode of death was apoptosis, as assessed by chromatin condensation, and the effects of methylglyoxal were observed to be complete by approximately eight hours. Yet, the impact of methylglyoxal was a function of the rate of dosing; stepwise addition of MG during the first 6 h of incubation inhibited growth but caused much less cell death than a comparable bolus dose. Inhibition of cellular metabolism by MG was found to coincide with inhibition of cell growth, with a comparable median inhibitory concentration of 360+/-20 muM. The effects on viable cell density and metabolism were both linear at doses approaching zero, with lowest observable effect levels of 54 and 77 muM, respectively. These results provide quantitative estimates for concentrations of methylglyoxal that may be inhibitory to biopharmaceutical-producing cell lines.
Related Concept Videos
Concentration Cells
Consider the following voltaic cell:
Hybridoma Technology
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
Solution Concentration and Dilution
Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies.
Stress Concentrations
The stress...
Stress Concentrations

